Mark Winstanley

544 total citations
12 papers, 227 citations indexed

About

Mark Winstanley is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Mark Winstanley has authored 12 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 4 papers in Pathology and Forensic Medicine and 3 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Mark Winstanley's work include Sarcoma Diagnosis and Treatment (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Mark Winstanley is often cited by papers focused on Sarcoma Diagnosis and Treatment (6 papers), Lymphoma Diagnosis and Treatment (4 papers) and Childhood Cancer Survivors' Quality of Life (3 papers). Mark Winstanley collaborates with scholars based in New Zealand, United States and Australia. Mark Winstanley's co-authors include Torsten O. Nielsen, Catherine J. Pallen, Paul W. Clarkson, Maureen J. O’Sullivan, Poul H. Sorensen, Douglas E. Horsman, Malcolm Hayes, Tony Ng, Jason Smith and C Wright and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Treatment Reviews and Molecular Cancer Research.

In The Last Decade

Mark Winstanley

11 papers receiving 224 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Winstanley New Zealand 6 151 67 52 47 44 12 227
Nilgün Kurucu Türkiye 8 111 0.7× 42 0.6× 44 0.8× 36 0.8× 60 1.4× 34 251
Chin-Yuan Tzen Taiwan 6 264 1.7× 37 0.6× 25 0.5× 22 0.5× 35 0.8× 7 315
A. Jacobson United States 9 176 1.2× 73 1.1× 30 0.6× 23 0.5× 92 2.1× 24 284
Michael G Feely United States 8 173 1.1× 34 0.5× 20 0.4× 91 1.9× 26 0.6× 9 272
Efrosyni Sfakianaki United States 7 255 1.7× 52 0.8× 53 1.0× 31 0.7× 204 4.6× 12 344
Patrick Hundsdörfer Germany 4 73 0.5× 18 0.3× 65 1.3× 14 0.3× 26 0.6× 11 184
N. Lessard France 6 154 1.0× 59 0.9× 59 1.1× 11 0.2× 22 0.5× 8 277
Marc R. Lewin United States 9 125 0.8× 40 0.6× 181 3.5× 14 0.3× 169 3.8× 11 300
Daniel Satgé France 10 43 0.3× 26 0.4× 29 0.6× 26 0.6× 59 1.3× 29 283
James P. McCarron United States 9 211 1.4× 61 0.9× 41 0.8× 84 1.8× 21 0.5× 10 356

Countries citing papers authored by Mark Winstanley

Since Specialization
Citations

This map shows the geographic impact of Mark Winstanley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Winstanley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Winstanley more than expected).

Fields of papers citing papers by Mark Winstanley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Winstanley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Winstanley. The network helps show where Mark Winstanley may publish in the future.

Co-authorship network of co-authors of Mark Winstanley

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Winstanley. A scholar is included among the top collaborators of Mark Winstanley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Winstanley. Mark Winstanley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Leung, Bonnie, et al.. (2025). Vascular encasement image defined risk factors independently predict surgical complications in neuroblastoma. ANZ Journal of Surgery. 95(6). 1147–1152.
2.
Connolly, Elizabeth A., Jeremy Lewin, Vivek A. Bhadri, et al.. (2024). High-dose chemotherapy for Ewing sarcoma and Rhabdomyosarcoma: A systematic review by the Australia and New Zealand sarcoma association clinical practice guidelines working party. Cancer Treatment Reviews. 124. 102694–102694. 1 indexed citations
3.
Clarke, Emma, Gemma Pugh, Pamela Cheung, et al.. (2023). Navigating nutrition as a childhood cancer survivor: Understanding patient and family needs for nutrition interventions or education. Nutrition & Dietetics. 80(5). 494–510. 3 indexed citations
4.
Clarke, Emma, et al.. (2023). Understanding the patient and family experience of nutrition and dietetic support during childhood cancer treatment. Supportive Care in Cancer. 31(6). 326–326. 3 indexed citations
5.
Taslim, Cenny, Jesse C. Crow, Peter Heppner, et al.. (2021). Identification of a Novel FUS/ETV4 Fusion and Comparative Analysis with Other Ewing Sarcoma Fusion Proteins. Molecular Cancer Research. 19(11). 1795–1801. 11 indexed citations
6.
Winstanley, Mark, et al.. (2020). Infantile B12 deficiency with severe thrombocytopenia-an under-recognised public health problem?. PubMed. 133(1516). 93–96. 3 indexed citations
7.
Wheatley, Keith, Bryar Kadir, Maria Khan, et al.. (2020). Correlation of response with progression-free (PFS) and overall (OS) survival in relapsed/refractory Ewing sarcoma (RR-ES): Results from the rEECur trial.. Journal of Clinical Oncology. 38(15_suppl). 11524–11524. 1 indexed citations
8.
McCabe, Martin G., Maria Khan, Nicola Fenwick, et al.. (2020). Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES).. Journal of Clinical Oncology. 38(15_suppl). 11502–11502. 32 indexed citations
9.
McCabe, Martin G., V. V. Moroz, Maria Khan, et al.. (2019). Results of the first interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma.. Journal of Clinical Oncology. 37(15_suppl). 11007–11007. 29 indexed citations
10.
Winstanley, Mark, Jason Smith, & C Wright. (2018). Catastrophic haemorrhage in military major trauma patients: a retrospective database analysis of haemostatic agents used on the battlefield. Journal of the Royal Army Medical Corps. 165(6). 405–409. 20 indexed citations
11.
Ballantine, Kirsten, Heidi Watson, Scott Macfarlane, et al.. (2017). Small Numbers, Big Challenges: Adolescent and Young Adult Cancer Incidence and Survival in New Zealand. Journal of Adolescent and Young Adult Oncology. 6(2). 277–285. 20 indexed citations
12.
Ng, Tony, Maureen J. O’Sullivan, Catherine J. Pallen, et al.. (2007). Ewing Sarcoma with Novel Translocation t(2;16) Producing an In-Frame Fusion of FUS and FEV. Journal of Molecular Diagnostics. 9(4). 459–463. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026